Remove 2030 Remove Diagnostic Remove Healthcare
article thumbnail

GE Healthcare, Hartford HealthCare extend Care Alliance agreement

AuntMinnie

GE HealthCare (GEHC) and Connecticut-based Hartford HealthCare have extended their "Care Alliance" collaboration through 2030. GEHC technicians will be available in-house to repair and complete maintenance on all equipment within the scope of the collaboration.

article thumbnail

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Imaging Technology

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030. In the U.S., doi: 10.2967/jnumed.123.265420

Clinic 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Companies Partner to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer

Imaging Technology

During Breast Cancer Awareness Month, it's especially important to highlight how by streamlining the diagnostic process for determining BRCA mutation status, we can expand access to BRCA testing and identify more gBRCAm patients more rapidly.

article thumbnail

Growth in Demand for Imaging Procedures Will Increase Need for Teleradiology

Vesta Teleradiology

The healthcare market is experiencing a shift towards outpatient care , driven by reimbursement changes, pandemic effects, and patient preferences, particularly prominent in the U.S. By the NuMbers Diagnostic imaging is becoming increasingly crucial in healthcare, with the market projected to reach $31.9bn in 2023 and grow at a 4.8%

article thumbnail

Lunit Announces Completion of Volpara Acquisition to Advance AI-driven Cancer Care

Imaging Technology

christine.book Wed, 05/22/2024 - 09:59 May 22, 2024 — Lunit , a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of its acquisition of Volpara Health Technologies, Ltd., a global developer of medical software for breast cancer screening.

article thumbnail

Lunit targets U.S. market, expanded AI portfolio with bid for Volpara

AuntMinnie

with Lunit’s complementing global footprint and AI expertise will create a compelling portfolio of advanced AI-enabled solutions for radiology and for other healthcare specialties," said Lunit CEO Brandon Suh in a statement. “Combining Volpara’s established presence in the U.S. The deal follows on recent U.S.

X-ray 112
article thumbnail

The Latest in Brain Imaging News

Vesta Teleradiology

In recent years, awareness surrounding brain injuries has steadily risen, prompting significant strides in diagnostic technologies and treatment modalities. The rise of AI in diagnostic imaging, projected to reach $1.2bn by 2027, signifies a transformative shift in improving accuracy and patient outcomes.

Imaging 52